ICMR Expands Research Funding and Invites Bids for Diagnostic Tech

The Indian Council of Medical Research (ICMR) has significantly expanded its grant architecture, with budgetary allocations rising to ₹4,000.00 crore in the 2026–27 Budget Estimates. This represents a 21% increase over the previous year's revised estimates, supporting diverse research initiatives ranging from small-scale grants to large Centres for Advanced Research.

In a parallel effort to boost indigenous diagnostic capabilities, the ICMR is inviting bids for the technology transfer of "MelioGlowPCR." This CRISPR-Cas-12a-based diagnostic kit is designed for the rapid detection of *Burkholderia pseudomallei*, the bacterium responsible for melioidosis. The technology is specifically engineered for use in resource-limited settings, combining multiplex PCR with CRISPR-based detection.

Beyond funding and technology, the Department of Health Research has released a draft National Health Research Policy 2026, which prioritizes real-world patient impact over academic output. Furthermore, a recent Parliamentary panel report has proposed 368 reforms to improve healthcare affordability and accessibility, including the launch of the National Health Claims Exchange (NHCX) to streamline insurance claim processes across the country.